Valitor

About:

Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..

Website: http://www.valitorbio.com/

Top Investors: Berkeley SkyDeck Fund, SkyDeck Berkeley, Morningside Venture Investments, First Spark Ventures, ExSight Ventures

Description:

Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity. Their technology platform can be broadly applied to improve the pharmacological properties of many protein drugs that are currently approved or under development. They currently have three development pipelines in the fields of dermatology, ophthalmology, and orthopedics that highlight the capabilities of their novel drug products. ​